Diabetic Cooking
Diabetic Diet Plan
Diabetic Food Pyramid
Diabetic Food
Diabetic Ketoacidosis
Diabetic Neuropathy
Diabetic Retinopathy
Diabetic Shoes
Diabetic Supply Testing
Diabetic Symptoms
Index of All Articles in the Diabetic Diet Plan Category
Defined Tag: Diabetic Diet Plan
Increasing Demand For A Diabetic Diet Plant Tells Of A Rising Number Of People Suffering From Diabetes
Living with diabetes is not easy no not by a long shot Since the body s ability to break down glucose, and with glucose being an important component in many vital processes for our existence, diabetes should be combated with efficiency and with expedien
Read More...
Diabetic Neuropathy News
| XTL Biopharmaceuticals Announces Top-Line Results From The Bicifadine Phase 2b Study For Diabetic Neuropathic Pain (Medical News Today) Wed, 19 Nov 2008 11:16:03 GMT XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announced the top-line results from the Bicifadine Phase 2b clinical trial for the treatment of diabetic neuropathic pain. The trial's primary objective was to compare the efficacy of two doses of Bicifadine against placebo in reducing pain associated with diabetic neuropathy. |
| (AFX UK Focus) 2008-11-18 14:05 UPDATE 1-XTL's diabetic pain drug fails in trial, shares sink (Interactive Investor) Tue, 18 Nov 2008 14:23:13 GMT Nov 18 (Reuters) - XTL Biopharmaceuticals Ltd said a mid-stage trial of its lead compound bicifadine, a treatment for diabetic neuropathic pain, failed to meet the main goal of the study, sending its shares tumbling 97 percent. The main goal of the trial was to compare the efficacy of two doses of bicifadine against a dummy drug in reducing pain associated with diabetic neuropathy, the company ... |
| XTL Biopharmaceuticals Announces Top-Line Results From the Bicifadine Phase 2b Study for Diabetic Neuropathic Pain (PR Newswire via Yahoo! Finance) Tue, 18 Nov 2008 13:05:00 GMT XTL Biopharmaceuticals Ltd. announced today the top-line results from the Bicifadine Phase 2b clinical trial for the treatment of diabetic neuropathic pain. The trial's primary objective was to compare the efficacy of two doses of Bicifadine against placebo in reducing pain associated with diabetic neuropathy. |